China Reinsurance (Group) Corporation (1508.HK)
Beijing, CN
China Reinsurance (Group) Corporation, along with its affiliated companies, functions as a leading reinsurance enterprise operating within the People's Republic of China and internationally. Its diverse business activities are structured into key segments, including Property and Casualty Reinsurance, Life and Health Reinsurance, Primary Property and Casualty Insurance, Asset Management, and other ancillary divisions. The company delivers a wide array of reinsurance solutions covering risks such as motor vehicles, commercial and household property, engineering, marine hull and cargo, liability, credit and guarantee, personal accident, health, agriculture, life and annuity, space and aviation, energy, and nuclear risks. Beyond reinsurance, it also offers comprehensive insurance agency services, which involve risk identification, assessment, and consultation; insurance program design and procurement; policy and claims administration; disaster and accident prevention management; holistic risk management; and the arrangement of reinsurance. Furthermore, its service portfolio extends to asset management, insurance brokerage, risk evaluation and oversight, underwriting agency services, risk advisory, management consulting, and investment management. The corporation is also active in issuing bonds. Its engagement also encompasses an e-commerce business and the provision of various multi-asset investment products, such as project-based financing programs, asset-backed securities, and investment initiatives for infrastructure and real estate. Established in 1949, China Reinsurance (Group) Corporation's principal office is located in Beijing, People's Republic of China, and it operates as a subsidiary of Central Huijin Investment Ltd.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.65% | -4.80% | -3.25% | -27.88% | -25.63% | -29.17% | +17.82% | +112.50% | +41.67% | -30.81% | -55.93% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | -1 |
| Buy | 1 | 0 |
| Hold | 4 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Insurance - Reinsurance: +19.7%+40.5% ★ Q4'25: +26.6% (vs Q4'23)
-
EPS growth Insurance - Reinsurance: +47.7%-12.0% Q4'25: -4.8% (vs Q4'23)
-
FCF margin FCF growth · Insurance - Reinsurance: +7.0%+8.3% Q4'25: +33.2% (vs Q4'23)
-
EBIT margin Insurance - Reinsurance: +13.4%+11.6% Q4'25: +8.3% (vs Q4'23)
-
ROIC Insurance - Reinsurance: +4.0%+6.6% ★ Q4'25: +9.7% (vs Q4'23)
-
Share dilution Insurance - Reinsurance: +0.2%+0.0% Q4'25: +0.0% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Reinsurance: 0.00×4.87× Q4'25: 3.30× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 4 EPS Ana. |
Dec 2027 1 Rev. Ana. 4 EPS Ana. |
Dec 2028 1 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
86.16B
est: 102.77B (-16.2%)
|
91.96B
est: 96.51B (-4.7%)
|
109.83B
est: 124.63B (-11.9%)
|
119.97B
est: 126.15B (-4.9%)
|
142.58B
est: 162.67B (-12.3%)
|
168.10B
est: 194.74B (-13.7%)
|
163.95B
est: 161.17B (+1.7%)
|
88.27B
est: 191.22B (-53.8%)
|
94.96B
est: 95.18B (-0.2%)
|
85.54B
est: 109.15B (-21.6%)
|
120.19B
est: 125.03B (-3.9%)
|
132.87B
132.87B – 132.87B
+6.3% YoY
|
138.36B
138.36B – 138.36B
+4.1% YoY
|
144.45B
144.45B – 144.45B
+4.4% YoY
|
| EBITDA |
830.32M
est: 7.79B (-89.3%)
|
1.17B
est: 11.35B (-89.7%)
|
502.12M
est: 8.43B (-94.0%)
|
-785.37M
est: 7.68B (-110.2%)
|
-1.05B
est: 6.34B (-116.5%)
|
10.25B
est: 9.19B (+11.5%)
|
10.38B
est: 9.61B (+8.0%)
|
1.85B
est: 11.43B (-83.8%)
|
3.28B
est: 8.26B (-60.3%)
|
17.04B
est: 9.47B (+79.9%)
|
13.93B
est: 10.85B (+28.3%)
|
11.53B
11.53B – 11.53B
+6.3% YoY
|
12.01B
12.01B – 12.01B
+4.1% YoY
|
12.54B
12.54B – 12.54B
+4.4% YoY
|
| EBIT |
10.37B
est: 6.61B (+56.9%)
|
91.60B
est: 8.65B (+958.7%)
|
109.86B
est: 4.61B (+2,280.5%)
|
118.52B
est: 5.11B (+2,219.3%)
|
143.87B
est: 5.32B (+2,606.7%)
|
9.05B
est: 6.18B (+46.4%)
|
9.16B
est: 6.46B (+41.7%)
|
565.62M
est: 7.69B (-92.6%)
|
1.97B
est: 7.30B (-73.0%)
|
15.81B
est: 8.38B (+88.7%)
|
13.93B
est: 9.59B (+45.1%)
|
10.20B
10.20B – 10.20B
+6.3% YoY
|
10.62B
10.62B – 10.62B
+4.1% YoY
|
11.09B
11.09B – 11.09B
+4.4% YoY
|
| Net Income |
7.58B
est: 7.92B (-4.3%)
|
5.15B
est: 7.61B (-32.3%)
|
5.26B
est: 5.17B (+1.7%)
|
3.73B
est: 4.76B (-21.7%)
|
6.05B
est: 4.21B (+43.8%)
|
5.71B
est: 5.66B (+0.8%)
|
5.95B
est: 5.92B (+0.5%)
|
-324.65M
est: 3.42B (-109.5%)
|
5.65B
est: 8.71B (-35.1%)
|
10.56B
est: 10.72B (-1.5%)
|
9.52B
est: 8.78B (+8.5%)
|
11.14B
10.31B – 11.96B
+26.9% YoY
|
11.85B
10.34B – 13.35B
+6.4% YoY
|
13.23B
12.12B – 14.34B
+11.7% YoY
|
| SGA |
2.67B
est: 7.23B (-63.1%)
|
3.60B
est: 11.06B (-67.5%)
|
3.55B
est: 11.24B (-68.4%)
|
4.05B
est: 10.24B (-60.4%)
|
9.01B
est: 14.38B (-37.3%)
|
9.94B
est: 15.39B (-35.4%)
|
7.45B
est: 16.09B (-53.7%)
|
7.79B
est: 19.14B (-59.3%)
|
7.81B
est: 5.57B (+40.1%)
|
6.57B
est: 6.39B (+2.9%)
|
—
est: 7.32B (-100.0%)
|
7.78B
7.78B – 7.78B
+6.3% YoY
|
8.10B
8.10B – 8.10B
+4.1% YoY
|
8.46B
8.46B – 8.46B
+4.4% YoY
|
| EPS |
0.20
est: 0.19 (+7.3%)
|
0.12
est: 0.13 (-5.0%)
|
0.12
est: 0.14 (-11.4%)
|
0.09
est: 0.13 (-31.3%)
|
0.14
est: 0.13 (+6.0%)
|
0.13
est: 0.15 (-14.9%)
|
0.14
est: 0.17 (-17.1%)
|
-0.01
est: 0.08 (-109.7%)
|
0.13
est: 0.21 (-36.6%)
|
0.25
est: 0.25 (-0.9%)
|
0.22
est: 0.28 (-20.9%)
|
0.26
0.24 – 0.28
-6.9% YoY
|
0.28
0.24 – 0.31
+7.9% YoY
|
0.30
0.29 – 0.34
+8.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-28 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-27 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-26 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-22 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-21 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-20 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-19 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-18 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-15 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-14 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-13 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-12 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-11 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-08 | A | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-07 | A | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-06 | A | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-05 | A | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-04 | A | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-29 | A | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-28 | A | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-27 | A | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-24 | A | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-23 | A | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-22 | A | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-21 | A | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-20 | A | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-15 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 4/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Shunming Cao | Chief Risk & Compliance Officer & Joint Company Secretary | 2M | male |
| Qianzhi Zhuang | Executive Chairman | 1M | male |
| Xiaoyun Zhu | President & Executive Vice Chairlady | 1M | female |
| Ruohong Luo | Vice President of China Re Assets | — | male |
| Man Nar Chung | Joint Company Secretary | — | female |
| Xiaomin Li | President of the China Continent Insurance | — | male |
| Xiaowei Lu | Vice President of China Continent Insurance | — | male |
| Shukai Liu | Director of BOD Office | — | — |
| Meipan Tian | VP, Chief Actuary & Chief Financial Officer | — | male |
| Renjiang Zhang | General Manager of China Re P&C | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 1508.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
